Mereo BioPharma Group PLC (MREO)
4.01
-0.27
(-6.31%)
USD |
NASDAQ |
Nov 04, 16:00
4.025
+0.02
(+0.37%)
After-Hours: 20:00
Mereo BioPharma Group Price to Book Value: 7.844 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.844 |
| November 01, 2024 | 8.372 |
| October 31, 2024 | 8.236 |
| October 30, 2024 | 8.314 |
| October 29, 2024 | 8.236 |
| October 28, 2024 | 8.216 |
| October 25, 2024 | 8.333 |
| October 24, 2024 | 8.509 |
| October 23, 2024 | 8.314 |
| October 22, 2024 | 8.548 |
| October 21, 2024 | 8.861 |
| October 18, 2024 | 9.038 |
| October 17, 2024 | 8.920 |
| October 16, 2024 | 8.822 |
| October 15, 2024 | 8.881 |
| October 14, 2024 | 8.744 |
| October 11, 2024 | 8.490 |
| October 10, 2024 | 8.059 |
| October 09, 2024 | 8.098 |
| October 08, 2024 | 8.138 |
| October 07, 2024 | 8.314 |
| October 04, 2024 | 8.607 |
| October 03, 2024 | 8.607 |
| October 02, 2024 | 8.392 |
| October 01, 2024 | 8.157 |
| Date | Value |
|---|---|
| September 30, 2024 | 8.040 |
| September 27, 2024 | 8.098 |
| September 26, 2024 | 8.020 |
| September 25, 2024 | 7.825 |
| September 24, 2024 | 7.922 |
| September 23, 2024 | 8.001 |
| September 20, 2024 | 8.314 |
| September 19, 2024 | 8.372 |
| September 18, 2024 | 8.255 |
| September 17, 2024 | 7.727 |
| September 16, 2024 | 8.803 |
| September 13, 2024 | 8.372 |
| September 12, 2024 | 8.588 |
| September 11, 2024 | 9.116 |
| September 10, 2024 | 9.174 |
| September 09, 2024 | 8.783 |
| September 06, 2024 | 8.451 |
| September 05, 2024 | 8.666 |
| September 04, 2024 | 8.509 |
| September 03, 2024 | 8.666 |
| August 30, 2024 | 9.174 |
| August 29, 2024 | 8.959 |
| August 28, 2024 | 9.135 |
| August 27, 2024 | 9.390 |
| August 26, 2024 | 9.526 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2881
Minimum
Dec 24 2019
15.16
Maximum
Jun 17 2024
3.545
Average
2.355
Median
Sep 30 2021
Price to Book Value Benchmarks
| NuCana PLC | 0.7245 |
| TC BioPharm (Holdings) PLC | 0.5039 |
| Adaptimmune Therapeutics PLC | 2.164 |
| Biodexa Pharmaceuticals PLC | 0.2989 |
| Bicycle Therapeutics PLC | 1.949 |
Price to Book Value Related Metrics
| Price | 4.01 |
| Earnings Yield | -6.58% |
| Market Cap | 616.95M |